LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,517,962 | -67.6% | 52,374 | -66.7% | 0.00% | -100.0% |
| Q2 2023 | $10,867,117 | +97.2% | 157,426 | +37.7% | 0.00% | +100.0% |
| Q1 2023 | $5,511,546 | -65.6% | 114,300 | -64.4% | 0.00% | -80.0% |
| Q4 2022 | $16,025,917 | -32.2% | 321,032 | -44.6% | 0.01% | -16.7% |
| Q3 2022 | $23,644,000 | +32.7% | 579,500 | +78.9% | 0.01% | +50.0% |
| Q2 2022 | $17,815,000 | +68.1% | 323,900 | +11.1% | 0.00% | +100.0% |
| Q1 2022 | $10,597,000 | +18.0% | 291,630 | +51.3% | 0.00% | – |
| Q4 2021 | $8,982,000 | +259.0% | 192,694 | +289.3% | 0.00% | – |
| Q3 2021 | $2,502,000 | -24.2% | 49,500 | -38.4% | 0.00% | – |
| Q2 2021 | $3,301,000 | +616.1% | 80,409 | +406.2% | 0.00% | – |
| Q1 2021 | $461,000 | – | 15,886 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |